242 2 WATSON Pill - white round, 7mm
Pill with imprint 242 2 WATSON is White, Round and has been identified as Lorazepam 2 mg. It is supplied by Watson Pharmaceuticals.
Lorazepam is used in the treatment of Anxiety; Insomnia; ICU Agitation; Epilepsy; Light Anesthesia and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 2 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for 242 2 WATSON
Lorazepam
- Imprint
- 242 2 WATSON
- Strength
- 2 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Benzodiazepine anticonvulsants, Benzodiazepines, Miscellaneous antiemetics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
lactose,
magnesium stearate,
microcrystalline cellulose,
polacrilin potassium
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00591-0242 | Watson Pharmaceuticals, Inc. |
63739-0501 (Discontinued) | McKesson Packaging Services |
55289-0594 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
66267-0608 | Nucare Pharmaceuticals Inc. (repackager) |
More about lorazepam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,049)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: benzodiazepine anticonvulsants
- Breastfeeding
Patient resources
Other brands
Ativan, Lorazepam Intensol, Loreev XR
Professional resources
- Lorazepam monograph
- Lorazepam (FDA)
- Lorazepam Concentrate (FDA)
- Lorazepam Injection (FDA)
- Lorazepam Oral Concentrate (FDA)
Other brands
Ativan, Ativan Injection, Lorazepam Intensol, Loreev XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.